Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation

Andrew D Wingate1, David G Campbell, Mark Peggie

  • 1MRC Protein Phosphorylation Unit, Faculty of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, UK.

The Biochemical Journal
|October 15, 2005
PubMed

Insights

Ribosomal S6 kinase (RSK) phosphorylates the nuclear orphan receptor Nur77 at Ser354, impacting its DNA binding. This RSK-mediated phosphorylation is crucial for Nur77 regulation in response to mitogenic signals.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Nur77 is a nuclear orphan receptor involved in transcription and apoptosis.
  • Phosphorylation at Ser354 may inhibit Nur77's DNA binding, but the responsible kinase is unknown.

Purpose of the Study:

  • Identify the kinase responsible for Nur77 phosphorylation at Ser354 in cells.
  • Investigate the functional consequences of this phosphorylation.

Main Methods:

  • In vitro kinase assays using purified kinases and Nur77.
  • In vivo studies in cell cultures to assess phosphorylation and protein interactions.
  • Analysis of related proteins Nurr1 and Nor1 phosphorylation.

Main Results:

  • RSK and MSK (mitogen- and stress-activated kinase) phosphorylate Nur77 at Ser354 in vitro.
  • RSK, activated by the MAPK cascade, is the primary kinase for Nur77 phosphorylation in cells.
  • Nur77 phosphorylation by RSK promotes 14-3-3 binding in vitro, but not in cells.
  • RSK also phosphorylates related proteins Nurr1 and Nor1.

Conclusions:

  • RSK is the key kinase phosphorylating Nur77 at Ser354 in response to mitogenic stimuli.
  • This phosphorylation event is conserved in related NR4A family members.
  • Further research is needed to clarify the in vivo implications of RSK-mediated Nur77 phosphorylation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...